Andrographolide.

Andrographolide is cleared largely by sulfation and glucuronidation, which keeps its systemic exposure low relative to the dose taken. Piperine slows several of those conjugating steps and is used in formulation for exactly that reason. The pairing is a formulation choice aimed at exposure, not an effect on any endpoint. No combination trial in people is cited here.

Andrographolide dissolves poorly in water and much better in lipid. A lipid vehicle keeps it in solution through the gut lumen instead of letting it precipitate. This is a delivery relationship rather than a biological one, and it says nothing about what happens after absorption.

Phospholipid dispersions hold lipophilic diterpenes in a mixed-micelle state that survives the aqueous phase of digestion. Lecithin is used in andrographolide preparations for that dispersion role. The role is physical, and the trade-off is added excipient mass per capsule.

Quercetin and andrographolide both dampen the same inflammatory signalling nodes in cultured cells and both are substrates for sulfation and glucuronidation. Because they compete for the same conjugating enzymes, exposure to each can shift when they are taken together. The interaction is mechanistic and has not been measured as a clinical outcome here.

Silymarin flavonolignans and andrographolide both engage the Keap1-Nrf2 axis that governs glutathione and quinone reductase output. Pairing them is a formulation convention in liver-support blends. Read it as mechanistic overlap rather than a demonstrated additive effect.

N-acetylcysteine supplies cysteine thiol that reacts with electrophilic lactones in the same way glutathione does. Co-dosing raises the pool of nucleophile competing for andrographolide. The consequence is chemical quenching, and no human study of the pairing is cited here.

Ascorbate works in the aqueous phase while andrographolide acts indirectly, by shifting cellular antioxidant enzyme output. The two sit at different points of the same defence network rather than duplicating each other. Neither the pairing nor its combined effect on any measured endpoint is grounded in a trial cited here.

Zinc is required for hundreds of enzymes and for normal development and function of immune cells, a settled nutritional fact. Andrographis preparations are commonly formulated alongside zinc for seasonal immune blends. The nutrient contribution is established; the combination itself is formulation convention.

Elderberry and Andrographis appear together across seasonal wellness formulas, a pairing driven by category convention rather than by combination data. Their constituent chemistry is unrelated, anthocyanins versus a diterpene lactone. Nothing here measures the pair.

Gingerols and andrographolide both act on eicosanoid signalling in cell models, and both appear in the same traditional preparations. The overlap is at the level of pathway description. It has not been measured as a combination in people in the sources here.

Licorice is a conventional harmoniser in multi-herb formulas that include bitter cooling herbs such as Andrographis. Glycyrrhizin carries its own mineralocorticoid activity affecting sodium and potassium handling, so the pairing changes more than taste. That property is the reason to keep this row on the page rather than a product surface.

Astragalus polysaccharides and Andrographis extracts are combined across commercial immune blends and in traditional practice. The rationale is complementary use, one tonifying and one cooling, not a shared molecular target. No combination measurement is cited.

EPA and DHA shift thromboxane production and lengthen bleeding time at higher intakes, which is settled pharmacology. Andrographolide has shown platelet aggregation effects in laboratory systems. Where two agents both nudge platelet behaviour the effects can add, which is worth flagging rather than promoting.

EGCG and andrographolide are both heavily glucuronidated and sulfated on first pass, so they compete for the same conjugating capacity. That competition can raise exposure to either one in a way neither dose predicts. The signalling overlap is mechanistic and described in cell work only.

Boswellic acids act on 5-lipoxygenase while andrographolide acts further upstream on transcriptional control of the same cascade. Formulators combine them for that reason. The combination has no measured endpoint in the sources cited here.

Resveratrol and andrographolide both raise antioxidant enzyme expression in cultured cells through overlapping transcriptional handles. Both also face the same conjugation-limited exposure problem after an oral dose. Read the pairing as mechanistic, not clinical.

Lipoic acid cycles between dithiol and disulfide forms and regenerates other antioxidants, and its reduced form is a reactive nucleophile. That reactivity means it can both support the cell redox network and chemically engage an electrophile such as andrographolide. The direction of the net effect is not settled in the sources here.

Both compounds are described as acting on AMPK-linked signalling in cultured cells and both are used in metabolic support formulas. Berberine also inhibits several drug-metabolising enzymes, which can alter co-dosed compound exposure. Nothing here measures the two together.